Industry Webcast

Abbott Cancer Screening: Cologuard Plus®, SimpleScreen™ CRC, and Cancerguard®: Comprehensive, Noninvasive Screening Solutions to Support Early Detection and PreventionIndustry Webcast Sponsored by Exact Sciences is now Abbott; Not for CME/CE Credit

Join us for an in-depth discussion on the evolving landscape of early cancer detection and the expanding role of innovative screening solutions. This session explores how the Cologuard Plus® test for colorectal cancer screening, SimpleScreen™ CRC a blood-based CRC screening test, and the Cancerguard® multi‑cancer early detection test work together to help clinicians identify more cancers at earlier, more treatable stages. 
Attendees will gain a deeper understanding of test performance, clinical integration, and how these tools can enhance confidence in early detection strategies. With cancer incidence rising in younger adults and most cancers lacking routine screening, this conversation offers timely practice‑enhancing insights. Join us to learn how expanding screening options may help advance outcomes across broader patient populations.